TCL Archive US Oncology Begins Phase III Trial Of Bcl-2 Antisense With Chemo For Melanoma. July 28, 2000
TCL Archive In Brief: New Contract To Speed Drug Development Planned; Groups To Get $5.6 Million Extra February 27, 1976